Essure Permanent Birth Control(Australasian Medical & Scientific Ltd - ESSURE System - Contraceptive, tubal occlusion, Insert) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Australasian Medical & Scientific Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2017-RN-01125-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2017-08-28
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Amsl is advising that all lots of essure are being removed due to a temporary suspension of the european ec certificate during the european certificate renewal process. further, post-market information suggests that some patients may not be fully informed of possible device & procedure related complications, including changes in menstrual bleeding, unintended pregnancy, chronic pain, perforation and migration of the device, allergy/hypersensitivity, or immune-type reactions.
  • 조치
    AMSL is requesting customers: 1. Inspect stock and quarantine all Essure kits and then email or call AMSL to arrange for the affected stock to be recovered. This information is required to reconcile this process. 2. If any of the recalled stock could have been possibly transferred from your hospital to another, please immediately let that hospital know of the recall action. It would be appreciated if you would then telephone AMSL so contact can be made with the hospital supplied from your hospital. A summary of changes to the labelling includes: - The addition of a Boxed Warning listing information on the ESSURE Confirmation test, adverse events that have been reported either in clinical studies or through post market surveillance and situations where device removal may be indicated. - The IFU has also been updated with additional information. This includes a new section on patient counselling in addition to revisions in the sections discussing safety, clinical studies, instructions for use and patient management. - The introduction of a PIB including a Checklist. The PIB, along with the Checklist, is intended to be reviewed by the physician and patient to facilitate the patient's understanding of birth control options, benefits and potential risks associated with the use of ESSURE, as well as what to expect during and after the ESSURE procedure. For more information, please see https://www.tga.gov.au/alert/essure-contraceptive-device

Device

  • 모델명 / 제조번호(시리얼번호)
    Essure Permanent Birth Control(Australasian Medical & Scientific Ltd - ESSURE System - Contraceptive, tubal occlusion, Insert)Catalogue Number/Order Code: ESS305All Batch NumbersARTG number 174123
  • Manufacturer

Manufacturer